Real-time enrollment status for this recurrent high grade glioma clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 6:19 PM UTC
| NCT Number | NCT05698524 |
| Recruiting Status | Recruiting |
| Condition | Recurrent High Grade Glioma |
| Phase | PHASE1 |
| Target Enrollment | 24 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Nebraska |
| Last Updated on CT.gov | April 17, 2026 (Apr 17, 2026) |
As of July 17, 2026: Clinical trial NCT05698524 is currently recruiting participants. This phase1 study for recurrent high grade glioma is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Nebraska. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05698524 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05698524 was last updated Apr 17, 2026 (April 17, 2026). HelloStudys verifies this status automatically.